Rivastigmine for Alzheimer's disease (French version)

Warning: Parameter 2 to onepixelout_swftools_flashvars() expected to be a reference, value given in module_invoke() (line 476 of /var/www/community.cochrane.org/includes/module.inc).

To browse Podcasts by topic, please visit the new Cochrane Summaries site here

The use of cholinesterase inhibitors in people with Alzheimer's disease has long been a focus of interest and concern. In this podcast, Jacqueline Birks, a researcher from Oxford, England, reports the results of an updated systematic review studying the benefits and harms of one of these agents, rivastigmine, including a novel mode of percutaneous administration. (French version)

This Podcast also available in: English

Play Now!

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

Download [mp3]  | Read Review
Updated on: April 30, 2014, 10:41

Comments for improvement or correction are welcome.
Email: techsupport@cochrane.org